Literature DB >> 27017562

Rivaroxaban-induced leukocytoclastic vasculitis: A challenging rash.

Gerard Chaaya1, Juan Jaller-Char2, Ejaz Ghaffar3, Analia Castiglioni4.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27017562     DOI: 10.1016/j.anai.2016.03.012

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN: 1081-1206            Impact factor:   6.347


× No keyword cloud information.
  6 in total

1.  Rivaroxaban-Induced Hypersensitivity Syndrome.

Authors:  Charles-Olivier Chiasson; Arnaud Canneva; François-Olivier Roy; Maxime Doré
Journal:  Can J Hosp Pharm       Date:  2017-08-31

2.  Apixaban-induced cutaneous leucocytoclastic vasculitis.

Authors:  Munim Khan; Mahmoud Y Madi; Joseph Rencic
Journal:  BMJ Case Rep       Date:  2020-08-24

3.  Leukocytoclastic Vasculitis Associated with a New Anticoagulant: Rivaroxaban.

Authors:  Nuri Barış Hasbal; Taner Baştürk; Yener Koç; Tuncay Sahutoğlu; Feyza Bayrakdar Çağlayan; Abdülkadir Ünsal
Journal:  Turk J Haematol       Date:  2016-10-31       Impact factor: 1.831

4.  Case of both rivaroxaban- and dabigatran-induced leukocytoclastic vasculitis, during management of pulmonary thromboembolism.

Authors:  Hong Lyeol Lee; Lucia Kim; Cheol Woo Kim; Jung Soo Kim; Hae Sung Nam; Jeong Seon Ryu
Journal:  Respir Med Case Rep       Date:  2019-01-25

5.  Complementary Use of U.S. FDA's Adverse Event Reporting System and Sentinel System to Characterize Direct Oral Anticoagulants-Associated Cutaneous Small Vessel Vasculitis.

Authors:  Mohamed Mohamoud; Casie Horgan; Efe Eworuke; Elizabeth Dee; Justin Bohn; Oren Shapira; Monica A Munoz; Danijela Stojanovic; Veronica Sansing-Foster; Adebola Ajao; Lois La Grenade
Journal:  Pharmacotherapy       Date:  2020-11-08       Impact factor: 6.251

6.  Non-hemorrhage-related adverse effects of rivaroxaban.

Authors:  Eliza C Christopoulou; Theodosios D Filippatos; Moses S Elisaf
Journal:  Arch Med Sci Atheroscler Dis       Date:  2017-12-31
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.